AbbVie Inc header image

AbbVie Inc

ABBV

Equity

ISIN null / Valor 20145667

New York Stock Exchange, Inc (2026-03-31)
USD 213.50+1.78%

AbbVie Inc
UMushroom community rating:

star star star star star
4.50 2 votes No rating yet
NegativeNeutralPositive

About company

AbbVie Inc. is a global biopharmaceutical company dedicated to researching, developing, and marketing innovative medicines and medical solutions. With a workforce of over 50,000 employees across more than 70 countries, AbbVie focuses on addressing complex health challenges and improving the quality of life for people around the world. The company has a significant presence in research and development (R&D) and manufacturing, with facilities in approximately 20 countries. AbbVie's portfolio includes treatments for over 75 conditions, and its products reach around 50 million people annually in 175 countries. The company also emphasizes collaboration, maintaining over 250 partnerships with biotech firms, universities, nonprofits, and government organizations to advance scientific discovery. AbbVie's commitment to innovation is underscored by its development pipeline, which includes more than 80 compounds, devices, or indications.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

3.81%1Y
35.0%3Y
99.6%5Y

Performance

27.0%1Y
24.1%3Y
23.0%5Y

Volatility

Market cap

376832 M

Market cap (USD)

Daily traded volume (Shares)

7,491,187

Daily traded volume (Shares)

1 day high/low

177.34 / 175.6

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.50

2 votes
Performance:
starstarstarstarstar
5.00
Innovation:
starstarstarstarstar
4.50
Society:
starstarstarstarstar
3.50
Nature:
starstarstarstarstar
3.50
Lou Charlotte Wehrli
Switzerland, 15 May 2024
star star star star star
Interesting Stock and business model. Since people are obsessed with health and beauty, there is potential there.
Luba Schoenig
Switzerland, 15 May 2024
star star star star star
AbbVie Inc. has demonstrated robust financial health in its first-quarter 2024 results.

EQUITIES OF THE SAME SECTOR

Icon PLC
Icon PLC Icon PLC Valor: 1017575
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.96%USD 105.10
Sandoz Group Ltd
Sandoz Group Ltd Sandoz Group Ltd Valor: 124359842
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%CHF 60.46
Gyre Therapeutics Inc
Gyre Therapeutics Inc Gyre Therapeutics Inc Valor: 130270397
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.88%USD 6.84
CG Oncology Inc
CG Oncology Inc CG Oncology Inc Valor: 131996952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.02%USD 63.96
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%USD 31.59
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.99%USD 27.00
Sotera Health Company
Sotera Health Company Sotera Health Company Valor: 57897071
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%USD 13.25
Quest Diagnostics Inc
Quest Diagnostics Inc Quest Diagnostics Inc Valor: 566162
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.84%USD 197.16
Arjo AB
Arjo AB Arjo AB Valor: 39115843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.22%SEK 24.96
BioVersys AG
BioVersys AG BioVersys AG Valor: 21036264
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.33%CHF 29.00